| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/07/2006 | US20060276512 Fumagillol derivatives and preparing method thereof |
| 12/07/2006 | US20060276511 Inhibitors of HCV replication |
| 12/07/2006 | US20060276510 Dihydropyridine compounds and compositions for headaches |
| 12/07/2006 | US20060276509 Tripeptidyl peptidase inhibitors |
| 12/07/2006 | US20060276508 Amide derivatives as somatostatin receptor 5 antagonists |
| 12/07/2006 | US20060276507 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/07/2006 | US20060276506 Compounds for the treatment of inflammatory disorders |
| 12/07/2006 | US20060276505 Acylhydrazine P2X7 antagonists and uses thereof |
| 12/07/2006 | US20060276504 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 12/07/2006 | US20060276502 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53. |
| 12/07/2006 | US20060276501 low dosage of zolpidem, or zolpidem hemitartrate with a buffer when formulated for delivery across the oral mucosa, can induce rapid onset of sleep without residual sedative effects upon awakening 2-4 hours late |
| 12/07/2006 | US20060276500 Compositions and methods for treating nocturnal acid breakthrough and other acid related disorders |
| 12/07/2006 | US20060276499 Imidazopyridine intermediates |
| 12/07/2006 | US20060276498 4,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of Tpl2 kinase and methods of making and using the same |
| 12/07/2006 | US20060276497 Novel multicyclic compounds and the use thereof |
| 12/07/2006 | US20060276496 Anti-Cytokine Heterocyclic Compounds |
| 12/07/2006 | US20060276495 Treatment methods of nasal congestion and nasal obstruction |
| 12/07/2006 | US20060276494 Novel sulfonamides as L-CPT1 inhibitors |
| 12/07/2006 | US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 12/07/2006 | US20060276492 Treating human immunodeficiency and hepatitis B infections; high activity, low toxicity |
| 12/07/2006 | US20060276491 Therapeutic compounds |
| 12/07/2006 | US20060276490 Thiopyrimidine and isothiazolopyrimidine Kinase Inhibitors |
| 12/07/2006 | US20060276489 Inhibitors of Tubulin Polymerization |
| 12/07/2006 | US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 12/07/2006 | US20060276487 New compounds useful for DPP-IV enzyme inhibition |
| 12/07/2006 | US20060276486 Lklf/klf2 gene expression promoter |
| 12/07/2006 | US20060276485 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 12/07/2006 | US20060276484 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction |
| 12/07/2006 | US20060276483 Aerosolized fluoroquinolones and uses thereof |
| 12/07/2006 | US20060276482 Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists |
| 12/07/2006 | US20060276481 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans |
| 12/07/2006 | US20060276480 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 12/07/2006 | US20060276479 Heterocyclic substituted piperazines with CXCR3 antagonist activity |
| 12/07/2006 | US20060276477 Treatment method for anemia |
| 12/07/2006 | US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid |
| 12/07/2006 | US20060276475 Triazolotriazines and pyrazolotriazines and methods of making and using the same |
| 12/07/2006 | US20060276474 Novel carboxylic acid derivatives, their preparation and use |
| 12/07/2006 | US20060276473 Use and administration of bacterial efflux pump inhibitors |
| 12/07/2006 | US20060276472 Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas |
| 12/07/2006 | US20060276471 Useful in therapy and treatment of diseases associated with a disregulated protein kinase activity like cancer; Aurora kinases |
| 12/07/2006 | US20060276470 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy |
| 12/07/2006 | US20060276469 3-Methanesulfonylquinolines as GABAB enhancers |
| 12/07/2006 | US20060276467 Sodium channel modulators |
| 12/07/2006 | US20060276466 Bicyclic heterocycles as HIV integrase inhibitors |
| 12/07/2006 | US20060276465 1,2-di(cyclic) substituted benzene compounds |
| 12/07/2006 | US20060276464 Diarylsulfone sulfonamides and use thereof |
| 12/07/2006 | US20060276463 Pure levofloxacin hemihydrate and processes for preparation thereof |
| 12/07/2006 | US20060276462 Method of treating cognitive decline due to sleep deprivation and stress |
| 12/07/2006 | US20060276461 Prostaglandin analogs |
| 12/07/2006 | US20060276460 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns |
| 12/07/2006 | US20060276459 Methods of treating cell proliferative disorders |
| 12/07/2006 | US20060276458 Therapeutic compositions and methods |
| 12/07/2006 | US20060276457 Piperazine-piperidines with CXCR3 antagonist activity |
| 12/07/2006 | US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia |
| 12/07/2006 | US20060276455 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia |
| 12/07/2006 | US20060276454 Monoamine re-uptake inhibitors and methods relating thereto |
| 12/07/2006 | US20060276453 and Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2 inhibitors, used for preventing or treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 12/07/2006 | US20060276452 Use of azetidinecarboxamide derivatives in therapy |
| 12/07/2006 | US20060276451 Inhibitors of production of cytokines interleukin-2 (IL-2) and tumor necrosis factor- alpha (TNF- alpha) |
| 12/07/2006 | US20060276450 Isoquinoline potassium channel inhibitors |
| 12/07/2006 | US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability |
| 12/07/2006 | US20060276448 Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 12/07/2006 | US20060276447 e.g. N-(2-Trifluoromethylphenyl)-N'-[(1-(6-trifluoromethyl-2-pyridyl)azetidin-3-yl)]urea; capsaicin receptor antagonist; analgesic, antiinflammatory agent; chronic, neuropathic, postoperative, postrheumatoid arthritic, osteoarthritic, back, visceral, cancer pain, algesia, neuralgia |
| 12/07/2006 | US20060276446 Tricyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors |
| 12/07/2006 | US20060276445 Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors |
| 12/07/2006 | US20060276444 Porphyrin-polyamine conjugates for cancer therapy |
| 12/07/2006 | US20060276443 21-substituted progesterone derivatives as new antiprogestational agents |
| 12/07/2006 | US20060276442 Testing a woman's blood to make sure it includes estradiol within a predetermined range and testosterone within a second predetermined range, then administrating a drug selected from the group consisting of vardenafil hydrochloride and tadalafil prior to sexual activity; dehydroepiandrosterone (DHEA) |
| 12/07/2006 | US20060276441 Medicaments comprising steroids and a novel anticholinergic |
| 12/07/2006 | US20060276440 Treatment of inflammatory disorders |
| 12/07/2006 | US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 12/07/2006 | US20060276438 Prevention and treatment of influenza with glutamine antagonist agents |
| 12/07/2006 | US20060276437 Process for producing optically active dihydropyridinephosphonic ester |
| 12/07/2006 | US20060276436 Farnesyl dibenzodiazepinone formulation |
| 12/07/2006 | US20060276435 N-blocked peptide proline boronate compounds; hyperproliferative disorders like cancer, neurodegeneration, cardiac hypertrophy, pain, migraine, neurotraumatic disease, cirrhosis, fibromatosis, and rheumatoid arthritis |
| 12/07/2006 | US20060276433 Hydrazone derivative |
| 12/07/2006 | US20060276432 Lipid-regulating agent and use thereof |
| 12/07/2006 | US20060276431 Methods for treating severe acute respiratory syndrome |
| 12/07/2006 | US20060276430 Formulations for mediating inflammation and for reducing blood cholesterol |
| 12/07/2006 | US20060276429 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 12/07/2006 | US20060276428 A1 adenosine receptor agonists |
| 12/07/2006 | US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/07/2006 | US20060276425 Antisense oligomers and methods for inducing immune tolerance and immunosuppression |
| 12/07/2006 | US20060276424 Compositions and Methods for Treatment of Prostate and Other Cancers |
| 12/07/2006 | US20060276423 Survivin-directed RNA interference-compositions and methods |
| 12/07/2006 | US20060276421 single-stranded oligonucleotide comprising a 5'-end sequence, an intermediate sequence and a 3'-end sequence, both ends having reverse complementarity with the intermediate sequence, intermediate sequence having loops at both ends; phosphate groups are not phosphorothioated; antiinflammatory agent |
| 12/07/2006 | US20060276419 Combined use of ribavirin and interferon beta in demyelinating diseases |
| 12/07/2006 | US20060276418 Daunorubicin compounds synthesized with uncommon sugars; enhanced effectiveness in treating various drug-resistant cancers; proximal saccharide group is substituted with azido group, alkyl triazole group or multiple Me, OH and OMe groups in combinations different from those of known daunorubicins |
| 12/07/2006 | US20060276417 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents |
| 12/07/2006 | US20060276416 Methods and compositions for treating flushing and drug induced weight gain |
| 12/07/2006 | US20060276415 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 12/07/2006 | US20060276414 Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
| 12/07/2006 | US20060276413 New effector conjugates, methods for their preparation and their pharmaceutical use |
| 12/07/2006 | US20060276412 Methods and compositions for managing psychotic disorders |
| 12/07/2006 | US20060276411 Novel non-selective cation channel in neuronal cells and methods for treating brain swelling |
| 12/07/2006 | US20060276410 Compounds and methods for selective inhibition of dipeptidyl peptidase-iv |
| 12/07/2006 | US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors |
| 12/07/2006 | US20060276408 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors |
| 12/07/2006 | US20060276407 Methods of treating hepatitis C virus |
| 12/07/2006 | US20060276406 Methods of treating hepatitis C virus |